Sun Pharma allots INR 7,816 crore of privately placed NCDs

Fund Raising View source PDF Explain this filing

SUNPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.6%Reaction day

₹1748.00

prior close

₹1756.10

announcement price

In-mkt

timing

Nifty 100market+0.7%-1.3% vs market

Pharmaceuticals peers, median of 174sector+1.2%-1.8% vs sector

On the reaction day the stock moved 1.3 pts less than Nifty 100 and 1.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

-0.0

15m

-0.2

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.6+0.7-1.3+1.2-1.8

Next day

+0.2+1.0-0.8+3.1-2.9

+0.5pendingpending+4.8-4.2

—————

15d

—————

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sun Pharma allotted rated, listed, unsecured NCDs worth INR 7,816 crore via private placement on 26 October 2026. Series A is INR 2,003 crore at 8.05% and Series B INR 5,813 crore at 8.20%. The INR 7,000 crore base issue was fully subscribed, with an INR 816 crore greenshoe exercised. Both mature on 27 October 2031; Series A has a put option on 27 March 2028.

Likely market impact

Raises capital without dilution but adds interest and repayment obligations. Stock impact depends on how funds are used, which is not stated.